UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 6, 2023
Accession Number:
0001213900-23-015842
Submission Type:
POS AM
CIK:
0001817944
Company Name:
Clarus Therapeutics Holdings, Inc.
File Number:
333-265187